David Gionco, Chief Accounting Officer at STEMLINE THERAPEUTICS INC (STML), sold 13,568 shares at $17.26 ($236K) on 2018-02-27, disclosed to the SEC on 2018-02-28.
Open-market sale of $236k STML by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.61 | 4,400 | $77K | 32.9% |
| 2 | $17.26 | 4,584 | $79K | 33.6% |
| 3 | $17.26 | 4,584 | $79K | 33.6% |
| Total | $17.37 avg | 13,568 | $236K | 100% |
| Filing → |
| STML | SELL | 2020-03-13 | $69K | — | Filing → |
| STML | SELL | 2020-02-28 | $118K | — | Filing → |
| STML | SELL | 2020-01-03 | $49K | — | Filing → |